BIOLASE Technology (BLIT) Receives FDA 510(k) Clearance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts BLTI Hot Sheet
Join SI Premium – FREE
BIOLASE Technology, Inc. (Nasdaq: BLTI) received 510(k) clearance from the FDA allowing it to market a version of its Waterlase MD Laser System for use in dermatological applications as well as general and plastic surgery.
You May Also Be Interested In
- Liberty Defense names former TSA official Steve Karoly to its board
- Truist on DigitalOcean (DOCN): 'attractive way to play higher pricing on compute'
- Rosenblatt on Super Micro Computer (SMCI): 'Still Undervalued'
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
